Clinigen Consulting
Insight
19 Jun 2017
21st Century Cures Act: Does a public expanded access policy actually mean improved access for patients?
IDIS Global Access
Article
01 Jun 2017
Access to Unlicensed Medicines - EAHP 2017 Satellite Symposium Report
Clinigen Group
Insight
02 May 2017
First journal to address the challenges of access to medicines
Clinical Trial Services
Insight
17 Feb 2017
Investigator Initiated Trials: Supply strategies to add value and reduce burden
Clinigen Consulting
Article
17 Jan 2017
Managed Access Programmes: a powerful source of real-world insight
IDIS Managed Access
Article
04 Jan 2017
Supplementing Clinical Development with a Managed Access Program
IDIS Global Access
Article
13 Dec 2016
Accessing Medicines that aren’t available in South Africa
Clinigen Consulting
Insight
01 Dec 2016
21st Century Cures Act – are you ready?
Clinigen Specialty Pharmaceuticals
Article
29 Nov 2016
Prevention of Toxicities by Cytoprotection: The Role of Amifostine in the Supportive Care of Cancer for Patients with...
IDIS Managed Access
Article
17 Nov 2016
An exciting outlook for pre-approval access and compassionate use.

Get In Touch

Contact us for expert information, advice, consultation or quotes.